Woodline Partners’s Kalaris Therapeutics KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$173K Buy
2024
Q4
$190K Buy
2024
Q1
Sell
2023
Q4
$1.71M Buy
2023
Q3
$4.44M Buy
2023
Q2
$5.88M Buy
2023
Q1
$3.94M Sell
2022
Q4
$5.58M Hold
2022
Q3
$8.58M Hold
2022
Q2
$4.24M Hold
2022
Q1
$7.34M Hold
2021
Q4
$14.1M Sell
2021
Q3
$36.6M Buy
2021
Q2
$28.1M Buy
2021
Q1
$27.6M Buy
2020
Q4
$40M Sell
2020
Q3
$32.8M Buy